In biotech, observes Vir Biotechnology president and CEO George Scangos, it’s especially crucial to fully understand the market, and the means by which a new therapy will be purchased, prescribed and distributed. Many scientifically successful drugs, he points out, have been commercial failures—further demonstrating the importance of making sure the market is prepared to accept (and pay for) a new therapy.
Related

Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.
Video
53 minutes
Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.

Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Video
54 minutes
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.

Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
Video
58 minutes
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.